{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:31:27Z","timestamp":1717115487275},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,30]]},"DOI":"10.7759\/cureus.61356","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T11:39:33Z","timestamp":1717069173000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Clinical Features, Management of Hypertension, and Predictors of Severity in Hospitalized Hypertensive COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Narendar","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Azhar","family":"Syed Sulaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furqan  K","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabbiya","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faheem","family":"Jhatial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Maisharah","family":"Sheikh Ghadzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Origin of SARS-CoV-2. (2020). Accessed. May 6, 2022: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/332197\/WHO-2019-nCoV-FAQ-Virus_origin-2020.1-eng.pdf.."},{"key":"ref2","unstructured":"Pakistan cases details. Accessed. July 10, 2023: https:\/\/covid.gov.pk\/stats\/pakistan."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.336","article-title":"258. Comparison of different COVID waves during COVID-19 pandemic: a retrospective study from a dedicated COVID-19 facility of Karachi Pakistan","volume":"9","author":"Sayeed MA","year":"2022","unstructured":"Sayeed MA. 258. Comparison of different COVID waves during COVID-19 pandemic: a retrospective study from a dedicated COVID-19 facility of Karachi Pakistan. Open Forum Infect Dis. 2022, 9:ofac492.336. 10.1093\/ofid\/ofac492.336","journal-title":"Open Forum Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270900","article-title":"Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination","volume":"17","author":"Kumar N","year":"2022","unstructured":"Kumar N, Sulaiman SA, Hashmi FK, Qureshi A, Shaib M, Alam S, Hussain M. Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination. PLoS ONE. 2022, 17:e0270900. 10.1371\/journal.pone.0270900","journal-title":"PLoS ONE"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.29228\/jrp.84","article-title":"An evaluation of public understanding regarding COVID-19 in Sindh, Pakistan: a focus on knowledge, attitudes and practices","volume":"25","author":"Kumar N","year":"2021","unstructured":"Kumar N, Sulaiman SA, Hashmi FK. An evaluation of public understanding regarding COVID-19 in Sindh, Pakistan: a focus on knowledge, attitudes and practices. J Res Pharm. 2021, 25:881-9. 10.29228\/jrp.84","journal-title":"J Res Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103599","article-title":"The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: a retrospective cohort study","volume":"77","author":"Alam MT","year":"2022","unstructured":"Alam MT, Mehdi A, Timsaal Y, et al.. The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: a retrospective cohort study. Ann Med Surg (Lond). 2022, 77:103599. 10.1016\/j.amsu.2022.103599","journal-title":"Ann Med Surg (Lond)"},{"key":"ref7","unstructured":"Noncommunicable diseases country profiles 2018. (2018). Accessed. April 16, 2023: https:\/\/apps.who.int\/iris\/handle\/10665\/274512."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104357","article-title":"Epidemiology and clinical features of COVID-19: a review of current literature","volume":"127","author":"Siordia JA Jr","year":"2020","unstructured":"Siordia JA Jr. Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol. 2020, 127:104357. 10.1016\/j.jcv.2020.104357","journal-title":"J Clin Virol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46943","article-title":"Disease outcomes of COVID-19 in diabetic and hypertensive patients during the hospital stay","volume":"15","author":"Abid A","year":"2023","unstructured":"Abid A, Umar A, Qamar S. Disease outcomes of COVID-19 in diabetic and hypertensive patients during the hospital stay. Cureus. 2023, 15:e46943. 10.7759\/cureus.46943","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14146","article-title":"Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: a retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital","volume":"23","author":"Sun Y","year":"2021","unstructured":"Sun Y, Guan X, Jia L, et al.. Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: a retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital. J Clin Hypertens (Greenwich). 2021, 23:218-31. 10.1111\/jch.14146","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.18313","article-title":"Predictors of mortality among hospitalized hypertensive patients with COVID-19 during third and fourth waves in Pakistan","volume":"18","author":"Kumar N","year":"2024","unstructured":"Kumar N, Sheikh Ghadzi SM, Rajpoot PL, et al.. Predictors of mortality among hospitalized hypertensive patients with COVID-19 during third and fourth waves in Pakistan. J Infect Dev Ctries. 2024, 18:177-87. 10.3855\/jidc.18313","journal-title":"J Infect Dev Ctries"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S456333","article-title":"Clinical characteristics and analysis of associated risk factors in patients with severe and non-severe COVID-19 infection","volume":"17","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Wang Z, Chen F, Xiong YX, Wang W, Huang JM, Fang W. Clinical characteristics and analysis of associated risk factors in patients with severe and non-severe COVID-19 infection. Infect Drug Resist. 2024, 17:1539-44. 10.2147\/IDR.S456333","journal-title":"Infect Drug Resist"},{"key":"ref13","article-title":"Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics","author":"Rifai N","year":"2014","unstructured":"Rifai N. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. Elsevier Health Sciences, 2014."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00627-2","article-title":"Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China","volume":"43","author":"Liu XQ","year":"2022","unstructured":"Liu XQ, Xue S, Xu JB, Ge H, Mao Q, Xu XH, Jiang HD. Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China. Acta Pharmacol Sin. 2022, 43:64-75. 10.1038\/s41401-021-00627-2","journal-title":"Acta Pharmacol Sin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40256","article-title":"Evaluation of outpatients in the post-COVID-19 period in terms of autonomic dysfunction and silent ischemia","volume":"15","author":"Karakayal\u0131 M","year":"2023","unstructured":"Karakayal\u0131 M, Artac I, Ilis D, et al.. Evaluation of outpatients in the post-COVID-19 period in terms of autonomic dysfunction and silent ischemia. Cureus. 2023, 15:e40256. 10.7759\/cureus.40256","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang JJ","year":"2020","unstructured":"Zhang JJ, Dong X, Cao YY, et al.. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020, 75:1730-41. 10.1111\/all.14238","journal-title":"Allergy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2020.100055","article-title":"Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: a nationwide observational study","volume":"4","author":"Sim BL","year":"2020","unstructured":"Sim BL, Chidambaram SK, Wong XC, et al.. Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: a nationwide observational study. Lancet Reg Health West Pac. 2020, 4:100055. 10.1016\/j.lanwpc.2020.100055","journal-title":"Lancet Reg Health West Pac"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020, 323:1061-9. 10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.06.008","article-title":"Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): a systematic review and meta-analysis","volume":"509","author":"Yamada T","year":"2020","unstructured":"Yamada T, Wakabayashi M, Yamaji T, Chopra N, Mikami T, Miyashita H, Miyashita S. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): a systematic review and meta-analysis. Clin Chim Acta. 2020, 509:235-43. 10.1016\/j.cca.2020.06.008","journal-title":"Clin Chim Acta"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820002010","article-title":"Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases","volume":"148","author":"Zhang L","year":"2020","unstructured":"Zhang L, Huang B, Xia H, et al.. Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases. Epidemiol Infect. 2020, 148:e199. 10.1017\/S0950268820002010","journal-title":"Epidemiol Infect"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy M","year":"2020","unstructured":"Soy M, Keser G, Atag\u00fcnd\u00fcz P, Tabak F, Atag\u00fcnd\u00fcz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020, 39:2085-94. 10.1007\/s10067-020-05190-5","journal-title":"Clin Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07144-5","article-title":"High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department","volume":"22","author":"Tong-Minh K","year":"2022","unstructured":"Tong-Minh K, van der Does Y, Engelen S, et al.. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department. BMC Infect Dis. 2022, 22:165. 10.1186\/s12879-022-07144-5","journal-title":"BMC Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2020.11.015","article-title":"Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19","volume":"156","author":"Deng F","year":"2021","unstructured":"Deng F, Zhang L, Lyu L, et al.. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (Engl Ed). 2021, 156:324-31. 10.1016\/j.medcle.2020.11.015","journal-title":"Med Clin (Engl Ed)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2020.04.009","article-title":"Elevated troponin in patients with coronavirus disease 2019: possible mechanisms","volume":"26","author":"Tersalvi G","year":"2020","unstructured":"Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated troponin in patients with coronavirus disease 2019: possible mechanisms. J Card Fail. 2020, 26:470-5. 10.1016\/j.cardfail.2020.04.009","journal-title":"J Card Fail"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00466-z","article-title":"D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study","volume":"8","author":"Yao Y","year":"2020","unstructured":"Yao Y, Cao J, Wang Q, et al.. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020, 8:49. 10.1186\/s40560-020-00466-z","journal-title":"J Intensive Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kahn SR","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS, et al.. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141:e195S-226S. 10.1378\/chest.11-2296","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/254393-exploring-the-clinical-features-management-of-hypertension-and-predictors-of-severity-in-hospitalized-hypertensive-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T11:39:37Z","timestamp":1717069177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/254393-exploring-the-clinical-features-management-of-hypertension-and-predictors-of-severity-in-hospitalized-hypertensive-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.61356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}